Epioxa ™ HD 0.239% / Epioxa ™ 0.177% (riboflavin 5’-phosphate ophthalmic solution) is now available for use in epithelium-on ...
The melanocortin 4 receptor agonist setmelanotide is now FDA approved for weight management in adults and children with ...
Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared ...
A federal court blocks changes to the childhood immunization schedule by the recently appointed vaccine advisory committee; higher dose Wegovy injection gets green light; Cosentyx expanded to include ...
Significantly lower risks for MACE, all-cause mortality, incident myocardial infarction, stroke seen for adults 50 years and older with ASCVD.
Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines ...
Retatrutide is an investigational once-weekly triple hormone (glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon) receptor agonist.
Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...
Clinical benefits of the talazoparib and enzalutamide combination extend to patients with both BRCA and non-BRCA homologous recombination repair gene alterations.
HealthDay News — For patients with knee osteoarthritis (OA), the prebiotic fiber inulin and physical therapy-supported exercise (PSE) produce meaningful reductions in pain, according to a study ...
Health officials in southern England are investigating a meningitis outbreak that has led to the deaths of 2 young people and sickened at least 11 others. Many of the cases were linked to students in ...
Oral icotrokinra is now FDA-approved for plaque psoriasis, offering a new systemic option for adults and adolescents who weigh at least 40kg.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results